Pipeline Assessment

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Assessment of pipeline activities around client’s area of interest to support strategic decisions

Problem Statement:

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.

Our Methodology:
  • Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products
  • Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena
  • Company Assessment via Funding/Collaboration/Partnership Analysis
  • Analyst Comments on R&D developments
Results:
  • Detailed pipeline profiles of T-Cell Receptor (TCR) products
  • Additional comments on Inactive (Discontinued and Dormant) products.
  • Therapeutic assessment of active pipeline products
  • Detailed profiles of Companies with key coverage of collaboration/partnering activities

Related Insights

Product Assessment
Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

View Case
Asset Prioritization
Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

View Case
Competitive Benchmarking
Competitive Benchmarking

A large pharmaceutical client based in Europe involved DelveInsight to identify patient advocacy strategies of companies operating in the Pharma sector of the European Union, to benchmark their efforts against their competitors. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.